52 
Roche adds to RNA drug deal streak with Ribometrix partnership
Bio Pharma Dive
JANUARY 6, 2021
The companies' pact is the latest addition to a growing list of deals involving startups developing chemical drugs to target RNA molecules
RNA Related Topics 
2nd RNA Editing Summit 2020
Pharma Phorum
OCTOBER 5, 2020
The only industry-led meeting showcasing the recent development of RNA editing mechanisms and dedicated to realizing the research and therapeutics opportunity of RNA editing as quickly as possible. The post 2nd RNA Editing Summit 2020 appeared first on.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Regulating the ribosomal RNA production line
Scienmag
JANUARY 22, 2021
coli enzyme synthesizing ribosomal RNA that shift it between turbo- and slow-modes depending on the bacteria’s growth rate Credit: Murakami Laboratory, Penn State The enzyme that makes RNA from a DNA template is altered to slow the production of ribosomal RNA (rRNA), the […].
3rd RNA-Targeted Drug Discovery Summit
Pharma Phorum
SEPTEMBER 1, 2020
The world of drug discovery and chemical probes is still protein-centric and developing highly selective small molecules targeting RNA is often considered to be an insurmountable challenge. Why You Should Attend the RNA- Targeted Drug Discovery Summit.
MatMaCorp’s COVID-19 2SF RNA Test Effective in Detecting Variants
BioTech 365
FEBRUARY 26, 2021
MatMaCorp’s COVID-19 2SF RNA Test Effective in Detecting Variants MatMaCorp’s COVID-19 2SF RNA Test Effective in Detecting Variants MatMaCorp’s COVID-19 2SF RNA test detects a highly conserved gene of SARS-CoV-2 and received FDA emergency use approval (EUA) to be performed … Continue reading → Business Wire
Skyhawk and Vertex Team Up on RNA Splicing-Based Therapies
BioSpace
DECEMBER 21, 2020
Skyhawk Therapeutics and Vertex Pharmaceuticals inked a strategic research collaboration and licensing deal focused on developing novel small molecules that modulate RNA splicing
Ribometrix and Genentech Partner in Potential $1 Billion+ RNA Deal
BioSpace
JANUARY 5, 2021
Durham, North Carolina-based Ribometrix announced a strategic collaboration deal with Genentech to identify and advance novel RNA-targeted small molecule therapeutics
2020 Outlook on the Global RNA Vaccine Patent Landscape – ResearchAndMarkets.com
BioTech 365
JANUARY 29, 2021
2020 Outlook on the Global RNA Vaccine Patent Landscape – ResearchAndMarkets.com 2020 Outlook on the Global RNA Vaccine Patent Landscape – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “RNA Vaccine Patent Landscape 2021” report has been added to ResearchAndMarkets.com’s offering.
PCI Biotech – release of the RNA Therapeutics Virtual Conference presentation
BioTech 365
FEBRUARY 10, 2021
PCI Biotech – release of the RNA Therapeutics Virtual Conference presentation PCI Biotech – release of the RNA Therapeutics Virtual Conference presentation Oslo (Norway), 10 February 2021 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing innovative therapeutics that … Continue reading → GlobeNewswire
#news #biotech Regulating the ribosomal RNA production line
BioTech 365
JANUARY 22, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Regulating the ribosomal RNA production line.The enzyme that makes RNA from a DNA template is altered to slow the production of ribosomal RNA (rRNA), the most abundant … Continue reading → #news
Ribometrix and Genentech Partner in Potential $1 Billion+ RNA Deal
The Pharma Data
JANUARY 5, 2021
Durham, North Carolina-based Ribometrix announced a strategic collaboration deal with Genentech , a Roche company, to identify and advance novel RNA-targeted small molecule therapeutics. Targeting RNA is believed to be a way to develop therapeutics for so-called undruggable proteins.
Locanabio Raises $100 Million to Advance RNA-Targeted Gene Therapies
BioSpace
DECEMBER 13, 2020
San Diego-based Locanabio secured $100 million in a Series B financing round that will be used to advance the company’s portfolio of novel RNA-targeted gene therapies for neurodegenerative, neuromuscular and retinal diseases
Genialis Harnesses RNA-seq Platform to Advance Precision Medicine Discoveries
BioTech 365
NOVEMBER 9, 2020
Genialis Harnesses RNA-seq Platform to Advance Precision Medicine Discoveries Genialis Harnesses RNA-seq Platform to Advance Precision Medicine Discoveries New partnerships in oncology R&D, software advances, and the appointment of a new Board member help drive therapeutic breakthroughs SAN RAMON, Calif.–(BUSINESS
NSF backs bioinformatics approach to understanding plant RNA modifications
Scienmag
AUGUST 4, 2020
Led by Boyce Thompson Institute’s Andrew Nelson, four partners will identify RNA modifications and develop resources that may lead to hardier crops Credit: Photo credit: Anna Nelson Dittrich ITHACA, NY, August 4, 2020 — RNA perform a variety of functions in cells, helping with everything from regulating genes to building proteins.
Locanabio’s RNA-Targeting Gene Therapy May Offer Durable Response for DM1 Patients
BioSpace
SEPTEMBER 22, 2020
RNA-binding proteins are emerging as the next generation of molecular medicine
Qiagen QIAxcel for DNA Fragment & RNA Analysis
BioTech 365
AUGUST 22, 2020
CHF 637,87Angebotsende: Mittwoch Sep-16-2020 4:36:52 CESTSofort-Kaufen für nur: CHF 637,87Sofort-Kaufen | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : Qiagen QIAxcel for DNA Fragment & RNA Analysis BioMarketplace You want to propose your products or a Biotech Company, a Biotech … Continue reading → #BioMarketplace #BioMarketplace_CH Qiagen
IdentifySensors Biologics Develops Fast, Accurate, Over-the-counter RNA COVID Self-test for Smartphone
BioTech 365
DECEMBER 23, 2020
Twist Bioscience to Offer Synthetic RNA Control for UK Variant Strain of SARS-CoV-2
BioTech 365
DECEMBER 23, 2020
Twist Bioscience to Offer Synthetic RNA Control for UK Variant Strain of SARS-CoV-2 Twist Bioscience to Offer Synthetic RNA Control for UK Variant Strain of SARS-CoV-2 — VUI-202012/01 Variant May Increase SARS-CoV-2 Transmissibility by 70% — — Controls to be … Continue reading → Business Wire
Putting a New Spin on RNA, Remix Launches with $81 Million
BioSpace
DECEMBER 7, 2020
In addition, Remix will now be able to advance its pipeline of RNA processing targeted therapeutics as well The funds will be used to support the development of the company’s REMaster technology platform.
UMD researchers develop tools to sharpen 3D view of large RNA molecules
Scienmag
OCTOBER 7, 2020
New technique breaks through a technology roadblock that limited RNA imaging for 50 years Credit: Kwaku Dayie/University of Maryland University of Maryland scientists have developed a method to determine the structures of large RNA molecules at high resolution.
2020 RNA Therapies in Oncology Analytical Tool – ResearchAndMarkets.com
BioTech 365
OCTOBER 14, 2020
DUBLIN–(BUSINESS WIRE)–The “RNA Therapies in Oncology: Analytical Tool” report has been added to ResearchAndMarkets.com’s offering. RNA Therapies in Oncology: Analytical Tool is the must have handbook for any business developer, BI/CI operative or clinical developer who needs to be on … Continue reading → Business Wire
Worldwide RNA Interference (RNAi) Drug Delivery Industry to 2025 – by Application, Technology and Region – ResearchAndMarkets.com
BioTech 365
DECEMBER 29, 2020
Worldwide RNA Interference (RNAi) Drug Delivery Industry to 2025 – by Application, Technology and Region – ResearchAndMarkets.com Worldwide RNA Interference (RNAi) Drug Delivery Industry to 2025 – by Application, Technology and Region – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “RNA Interference (RNAi) Drug … Continue reading → Business Wire
University of Birmingham researchers develop rapid COVID-19 RNA test
Pharma Times
JANUARY 6, 2021
Test can give accurate results in under five minutes, according to researchers
#news #biotech New technique reveals switches in RNA
BioTech 365
FEBRUARY 22, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: New technique reveals switches in RNA.Scientists at the University of Groningen (The Netherlands), in collaboration with colleagues from the University of Torino (Italy), have developed a method … Continue reading → #news
Untangling the Body’s Smart Sensors: What RNA Binding Proteins Can Tell Us About Gene Regulation
BioSpace
SEPTEMBER 10, 2020
I certainly can’t, but Eclipse BioInnovations, a San Diego-based biotech start-up, is aiming to do just that for RNA therapeutics Can you imagine organizing more than 10 terabytes of data into a useful network of information, like creating Google maps from scratch?
Global RNA-interference (RNAi) Market Outlook 2020-2025: Improving Synthetic Delivery Carriers and Chemical Modifications to RNA – ResearchAndMarkets.com
BioTech 365
AUGUST 28, 2020
DUBLIN–(BUSINESS WIRE)–The “RNA-interference (RNAi) Market – Growth, Trends, and Forecast (2020 – 2025)” report has been added to ResearchAndMarkets.com’s offering. The RNA-interference (RNAi) market is expected to witness a CAGR of 10.12% during the forecast period.
#news #biotech A new RNA catalyst from the lab
BioTech 365
OCTOBER 28, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: A new RNA catalyst from the lab.Enzymes enable biochemical reactions that would otherwise not take place on their own. In nature, it is mostly proteins that function … Continue reading → #news
Small molecule targets SARS-CoV-2 RNA for destruction
Scienmag
SEPTEMBER 30, 2020
Now, researchers reporting in ACS Central Science have identified small molecules that target a structure within the RNA genome […]. SARS-CoV-2, the virus responsible for COVID-19, has wreaked havoc on health care systems, economies and everyday lives worldwide. Scientists are fighting back with multiple strategies, including vaccines, repurposed drugs developed for other diseases and brand-new therapies.
Circular RNA regulates neuronal differentiation by scaffolding an inhibitory transcription complex
Scienmag
NOVEMBER 13, 2020
In a screening for a functional impact to the neuronal differentiation process, Danish researchers identified a specific circular RNA, circZNF827, which surprisingly “taps the brake” on neurogenesis. Credit: Christian Kroun Damgaard and Anne Kruse Hollensen.
Amount of COVID viral RNA detected at hospital admission predicts how patients will fare
Scienmag
OCTOBER 29, 2020
29, 2020– A new study published online in the Annals of the American Thoracic Society examines whether the amount of RNA, or genomic load, of SARS-CoV-2 detected in swab tests of patients being admitted to the hospital with viral pneumonia is associated with more severe COVID-19.
#news #biotech Using machine learning to identify ancient RNA viruses in the human genome
BioTech 365
JANUARY 26, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Using machine learning to identify ancient RNA viruses in the human genome.A team of researchers affiliated with multiple institutions in Japan has used machine learning algorithms to … Continue reading → #news
Small RNA as a central player in infections
Scienmag
OCTOBER 15, 2020
Credit: (Image: Chair of Molecular Infection Biology II / University of Wuerzburg / SCIGRAPHIX) More than half of the world’s population carries the bacterium Helicobacter pylori in their stomach mucosa.
#news #biotech New computational tool reliably differentiates between cancer and normal cells from single-cell RNA-sequencing data
BioTech 365
JANUARY 18, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: New computational tool reliably differentiates between cancer and normal cells from single-cell RNA-sequencing data.In an effort to address a major challenge when analyzing large single-cell RNA-sequencing datasets, … Continue reading → #news
Dyne Therapeutics Myotonic Dystrophy Type 1 Program Achieves Robust RNA Knock Down of Toxic Human Nuclear DMPK in Preclinical Study
BioTech 365
JANUARY 10, 2021
Dyne Therapeutics Myotonic Dystrophy Type 1 Program Achieves Robust RNA Knock Down of Toxic Human Nuclear DMPK in Preclinical Study Dyne Therapeutics Myotonic Dystrophy Type 1 Program Achieves Robust RNA Knock Down of Toxic Human Nuclear DMPK in Preclinical Study … Continue reading → GlobeNewswire
MiNA Therapeutics Secures £23 Million Series A Financing to Advance First-in-Class Activating RNA-Based Therapeutics
BioTech 365
SEPTEMBER 10, 2020
Moderna Applies for Emergency F.D.A. Approval for Its Coronavirus Vaccine
NY Times
NOVEMBER 30, 2020
Vaccination and Immunization Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Research RNA (Ribonucleic Acid) Food and Drug Administration Moderna Inc National Institute of Allergy and Infectious Diseases your-feed-healthcareThe first shots could be given as early as Dec.
#news #biotech Sirnaomics nabs a major $105M funding round for next stage of its RNA work
BioTech 365
OCTOBER 23, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Sirnaomics nabs a major $105M funding round for next stage of its RNA work.Sirnaomics nabs a major $105M funding round for next stage of its RNA work … Continue reading → #news
?Arrakis Therapeutics Publishes Advanced Research Method To Systematically Identify RNA-Targeted Small Molecules
BioTech 365
AUGUST 31, 2020
Technology platform tool, PEARL-seq™, identifies binding sites in RNA by integrating proprietary bioinformatics workflow with chemical biology techniques for the rational design of rSM therapeutics WALTHAM, Mass.–(BUSINESS
#news #biotech Breast cancer study uncovers new RNA targets for treatment and diagnostics
BioTech 365
OCTOBER 19, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Breast cancer study uncovers new RNA targets for treatment and diagnostics.Breast cancer study uncovers new RNA targets for treatment and diagnostics arlene.weintraub Mon, 10/19/2020 – 08:41 from … Continue reading → #news
Let's personalize your content